What are the causes of elevated bilirubin in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Causes of Elevated Bilirubin in Pregnancy

Elevated bilirubin in pregnancy is most commonly caused by gallstones (25%) and preeclampsia-related disorders including HELLP syndrome (24%), followed by intrahepatic cholestasis of pregnancy (ICP) (13%), with viral hepatitis no longer being a frequent cause in the United States. 1

Primary Etiologies (in Order of Frequency)

1. Gallstone Disease (25%)

  • Most common cause of hyperbilirubinemia in contemporary pregnant populations
  • Represents a dramatic shift from historical data when viral hepatitis predominated
  • Requires consideration of cholecystectomy, which can be safely performed in any trimester 2

2. Preeclampsia/Eclampsia/HELLP Syndrome (24%)

  • Second most common cause
  • HELLP syndrome specifically involves hemolysis, elevated liver enzymes, and low platelets
  • These conditions require planning for delivery and timely evaluation for possible liver transplantation 2
  • Daily aspirin prophylaxis should begin at week 12 of gestation for at-risk patients 2

3. Intrahepatic Cholestasis of Pregnancy (13%)

  • Presents with pruritus in second/third trimester
  • Bilirubin typically remains <6 mg/dL in ICP 2
  • If bilirubin is markedly or persistently elevated in suspected ICP, investigate alternative causes 3
  • Diagnosed by serum bile acids >10 μmol/L with pruritus 2

4. Acute Fatty Liver of Pregnancy (AFLP)

  • Less common but life-threatening
  • Requires urgent delivery and intensive supportive care 4
  • May necessitate liver transplantation evaluation 2

5. Hyperemesis Gravidarum (5%)

  • Typically causes mild transaminase and bilirubin elevation
  • Managed supportively with nutritional intervention 4

6. Viral Hepatitis (6%)

  • No longer a common cause in the United States due to vaccination programs and demographic shifts 1
  • Still requires exclusion, particularly hepatitis C 3

7. Other Causes to Exclude

  • Extrahepatic biliary obstruction (ultrasound evaluation) 3
  • Autoimmune hepatitis (check AMA, ANA, SMA) 3
  • Pre-existing chronic liver disease 3
  • Sepsis 5
  • Genetic disorders (e.g., UGT1A1 polymorphisms, Crigler-Najjar syndrome) 6, 7

Critical Clinical Pitfalls

When evaluating elevated bilirubin in pregnancy, the level of bilirubin elevation provides diagnostic clues:

  • Bilirubin >6 mg/dL is unusual for ICP alone and should prompt investigation for alternative or concurrent diagnoses 2
  • Marked hyperbilirubinemia may indicate AFLP, HELLP syndrome, or underlying genetic disorders 6

Maternal hyperbilirubinemia carries significant fetal risk:

  • Increased stillbirths, fetal malformations, neonatal deaths, and small-for-gestational-age births 1
  • Maternal bilirubin levels predict both maternal and fetal adverse outcomes 5

Diagnostic Approach

When confronted with elevated bilirubin in pregnancy:

  1. Assess timing and symptoms: Pruritus suggests ICP; hypertension/proteinuria suggests preeclampsia spectrum
  2. Measure serum bile acids: Essential for ICP diagnosis (>10 μmol/L diagnostic) 2
  3. Check complete liver panel: ALT, AST, alkaline phosphatase, GGT 3
  4. Evaluate for preeclampsia: Blood pressure, proteinuria, platelet count 3
  5. Ultrasound abdomen: Rule out biliary obstruction 3
  6. Serologic testing: HCV, autoimmune markers if indicated 3

The combination of ALT, bilirubin, GGT, and alkaline phosphatase can generate a laboratory score that reliably predicts adverse outcomes 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.